Nfomedia

 

« return
 


Pharm G. 

 | Send Nfo Mail
One of PDGâ??s primary goals (and successes) in Pre-IND Meetings and through the compilation and submission of the IND is to provide FDA with developmental context as well as assurance that they will receive a complete and timely protocol for SPA consideration.

Call : +1.813.333.2950
Email : info@pharmdevgroup.com
Visit : https://pharmdevgroup.com/investigational-new-drug-application-indspecial-protocol-assessment/
 
Pharm is a member of 0 site(s) and has 0 contact(s).

 
Add a comment to Pharm's profile
 
Comments: